Hepatitis Forums
Fatty Liver Disease Main Forums => Nonalcoholic Steatohepatitis (NASH) => Topic started by: Hep Editors on November 20, 2019, 11:24:01 am
-
Researchers have developed a new, safer, more sensitive MRI dye for diagnosing liver disease in its early stages. If more advanced testing of the dye goes well and it is approved by the Food and Drug Administration, it could become a new noninvasive method for detecting such disease, a much-needed alternative to invasive surgical biopsies.
The research team, which published its findings in Nature Communications, was led by Jenny Yang, a regents’ professor in chemistry at Georgia State University and the associate director of the university’s Center for Diagnostics and Therapeutics. The investigation was supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), which is a division of the National Institutes of Health, as well as by Yang’s start-up company, InLighta BioSciences. Investigators at Emory University also contributed.
Read more...
https://www.hepmag.com/article/new-mri-contrast-dye-better-detects-earlystage-liver-disease